Mitochondrial targeting with antioxidant peptide SS-31 prevents mitochondrial depolarization, reduces islet cell apoptosis, increases islet cell yield, and improves posttransplantation function.

Apoptotic cell death is a defined pathway for islet cell demise, and mitochondrial dysfunction contributes to islet cell apoptosis. The hypothesis that the novel peptide D-Arg-2', 6'-dimethyltyrosine-Lys-Phe-NH2 (SS-31), previously shown to target inner mitochondrial membrane and prevent oxidative damage of neuronal cells and other cell types, optimizes pancreatic islet isolation and improves posttransplantation function in recipients with diabetes was investigated. Herein is demonstrated that SS-31 readily penetrates intact mouse islets, preserves mitochondrial polarization, reduces islet cell apoptosis, and increases islet cell yield. Optimization of islet isolation is demonstrable after SS-31 pretreatment of islet (pancreas) donor mice and with the addition of SS-31 to reagents that are used in the isolation of mouse islets. The supplementation of in vitro culture medium with SS-31 reduced islet cell apoptosis and increased the viability of human islets, as ascertained by dual-parameter flow cytometry analysis. In a stringent marginal islet cell mass transplantation model (200 mouse islets transplanted under the renal capsule of syngeneic diabetic mice) and using islets that were derived from old mice (>24 wk), SS-31 treatment was associated with prompt and sustained normoglycemia, whereas the untreated islet graft recipients remained diabetic. Our data suggest a novel strategy to optimize islet isolation and reduce the need for multiple pancreata to achieve insulin independence in the recipient with type 1 diabetes. Because SS-31 was effective with "extended" islet donors, it is hypothesized that the antioxidant SS-31 may serve to increase the pool of eligible organ donors.

[1]  M. Hong,et al.  Potent mitochondria-targeted peptides reduce myocardial infarction in rats , 2007, Coronary artery disease.

[2]  Philippe Morel,et al.  International trial of the Edmonton protocol for islet transplantation. , 2006, The New England journal of medicine.

[3]  A. Shapiro,et al.  Interventional Strategies to Prevent β-Cell Apoptosis in Islet Transplantation , 2006, Diabetes.

[4]  H. Szeto Cell-permeable, mitochondrial-targeted, peptide antioxidants , 2006, The AAPS Journal.

[5]  M. W. Anders,et al.  Targeting antioxidants to mitochondria: a new therapeutic direction. , 2006, Biochimica et biophysica acta.

[6]  H. Szeto,et al.  Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines. , 2005, Biochemical pharmacology.

[7]  J. Lakey,et al.  Intra‐Ductal Glutamine Administration Reduces Oxidative Injury During Human Pancreatic Islet Isolation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  R. Korneluk,et al.  XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes. , 2005, Diabetes.

[9]  R. Korneluk,et al.  The X-linked inhibitor of apoptosis protein enhances survival of murine islet allografts. , 2005, Diabetes.

[10]  T. D. Pugh,et al.  Mitochondrial DNA Mutations, Oxidative Stress, and Apoptosis in Mammalian Aging , 2005, Science.

[11]  E. Salvaris,et al.  Overexpression of glutathione peroxidase with two isoforms of superoxide dismutase protects mouse islets from oxidative injury and improves islet graft function. , 2005, Diabetes.

[12]  J. Beckmann,et al.  Intracellular stress signaling pathways activated during human islet preparation and following acute cytokine exposure. , 2004, Diabetes.

[13]  R. Bottino,et al.  Response of human islets to isolation stress and the effect of antioxidant treatment. , 2004, Diabetes.

[14]  H. Szeto,et al.  Cell-permeable Peptide Antioxidants Targeted to Inner Mitochondrial Membrane inhibit Mitochondrial Swelling, Oxidative Cell Death, and Reperfusion Injury* , 2004, Journal of Biological Chemistry.

[15]  G. Paradies,et al.  Role of Reactive Oxygen Species and Cardiolipin in the Release of Cytochrome C from Mitochondria , 2022 .

[16]  H. Szeto,et al.  Comparison of [Dmt1]DALDA and DAMGO in Binding and G Protein Activation at μ, δ, and κ Opioid Receptors , 2003, Journal of Pharmacology and Experimental Therapeutics.

[17]  J. C. Ferrer-García,et al.  Insulin-Induced Normoglycemia Reduces Islet Number Needed to Achieve Normoglycemia after Allogeneic Islet Transplantation in Diabetic Mice , 2003, Cell transplantation.

[18]  S. Orrenius Mitochondrial regulation of apoptotic cell death. , 2003, Toxicology letters.

[19]  T. Matsuda,et al.  Pancreas preservation by the 2-layer cold storage method before islet isolation protects isolated islets against apoptosis through the mitochondrial pathway. , 2003, Surgery.

[20]  C. Zeiss,et al.  The Apoptosis-Necrosis Continuum: Insights from Genetically Altered Mice , 2003, Veterinary pathology.

[21]  C. Ferran,et al.  Genetic Engineering of a Suboptimal Islet Graft with A20 Preserves β Cell Mass and Function1 , 2003, The Journal of Immunology.

[22]  D. Boffa,et al.  Erratum: Proapoptotic bax is hyperexpressed in isolated human islets compared with antiapoptotic bcl-2 (Transplantation (2002) 74: 11 (1489)) , 2003 .

[23]  Simon C Watkins,et al.  Gene transfer of manganese superoxide dismutase extends islet graft function in a mouse model of autoimmune diabetes. , 2003, Diabetes.

[24]  H. Szeto,et al.  Transcellular Transport of a Highly Polar 3+ Net Charge Opioid Tetrapeptide , 2003, Journal of Pharmacology and Experimental Therapeutics.

[25]  D. Boffa,et al.  Proapoptotic bax is hyperexpressed in isolated human islets compared with antiapoptotic bcl-21 , 2002, Transplantation.

[26]  D. Boffa,et al.  Enforced c-REL deficiency prolongs survival of islet allografts1 , 2002, Transplantation.

[27]  R. Jackson,et al.  Reactive species mechanisms of cellular hypoxia-reoxygenation injury. , 2002, American journal of physiology. Cell physiology.

[28]  G. Korbutt,et al.  SERINE-PROTEASE INHIBITION DURING ISLET ISOLATION INCREASES ISLET YIELD FROM HUMAN PANCREASES WITH PROLONGED ISCHEMIA1 , 2001, Transplantation.

[29]  C. Ricordi,et al.  Early assessment of apoptosis in isolated islets of Langerhans. , 2001, Transplantation proceedings.

[30]  C. Ricordi,et al.  ENDOTOXIN-MEDIATED DELAYED ISLET GRAFT FUNCTION IS ASSOCIATED WITH INCREASED INTRA-ISLET CYTOKINE PRODUCTION AND ISLET CELL APOPTOSIS1 , 2001, Transplantation.

[31]  P. Schiller,et al.  Synthesis and in vitro opioid activity profiles of DALDA analogues. , 2000, European journal of medicinal chemistry.

[32]  C. Reutelingsperger,et al.  Flow cytometry of apoptotic cell death. , 2000, Journal of immunological methods.

[33]  Guido Kroemer,et al.  Mitochondrial control of cell death , 2000, Nature Medicine.

[34]  G. Kroemer,et al.  Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis , 2000, Oncogene.

[35]  Robin A. J. Smith,et al.  Selective targeting of an antioxidant to mitochondria. , 1999, European journal of biochemistry.

[36]  S. Browne,et al.  Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[38]  S. Bonner-Weir,et al.  Vulnerability of Islets in the Immediate Posttransplantation Period: Dynamic Changes in Structure and Function , 1996, Diabetes.

[39]  M. Suarez‐Almazor,et al.  Variables in organ donors that affect the recovery of human islets of Langerhans. , 1996, Transplantation.

[40]  C Haanen,et al.  A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. , 1995, Journal of immunological methods.

[41]  J. Miquel,et al.  N-acetylcysteine protects against age-related decline of oxidative phosphorylation in liver mitochondria. , 1995, European journal of pharmacology.

[42]  J. Thistlethwaite,et al.  THE CORRELATION BETWEEN DONOR CHARACTERISTICS AND THE SUCCESS OF HUMAN ISLET ISOLATION1,2 , 1994, Transplantation.

[43]  O. Korsgren,et al.  Hyperglycemia-induced B cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background. , 1990, The Journal of clinical investigation.

[44]  A. Shapiro,et al.  Interventional strategies to prevent beta-cell apoptosis in islet transplantation. , 2006, Diabetes.

[45]  M. Beal,et al.  Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis. , 2006, Journal of neurochemistry.

[46]  J. C. Ferrer-García,et al.  Insulin-induced normoglycemia reduces islet number needed to achieve normoglycemia after allogeneic islet transplantation in diabetic mice. , 2003, Cell transplantation.

[47]  G.,et al.  Annexin V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis , 2000 .

[48]  Ames,et al.  Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen , 2000 .

[49]  L. Packer,et al.  Vitamin E reduces oxidant injury to mitochondria and the hepatotoxicity of taurochenodeoxycholic acid in the rat. , 1998, Gastroenterology.